NHS improves genetic testing for minority ethnic cancer patients

The NHS is implementing improved genetic testing for minority ethnic cancer patients, addressing previous gaps that overlooked gene variants linked to higher chemotherapy side effect risks. This change aims to reduce disparities in health outcomes for Black and minority ethnic patients, who historically face poorer post-diagnosis results compared to white patients.